NCT02960542 (HELP PC) is a NA clinical trial of HELP Prevent Cancer Intervention in Obesity, sponsored by Wake Forest University Health Sciences.

Who is sponsoring NCT02960542?

NCT02960542 is sponsored by Wake Forest University Health Sciences.

What drugs are being tested in NCT02960542?

Interventions in NCT02960542: HELP Prevent Cancer Intervention.

What condition does NCT02960542 study?

NCT02960542 studies Obesity, Cancer.

Is NCT02960542 still recruiting?

NCT02960542 is currently completed. Last updated 19 June 2020.

Last reviewed 2020-06-19 · How we verify

NCT02960542: HELP PC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HELP Prevent Cancer Pilot Study

Completed NA Last updated 19 June 2020

What this trial tests

NA trial testing HELP Prevent Cancer Intervention in Obesity in 21 participants. Completed in 4 April 2018.

Timeline

26 June 2017

Primary endpoint
4 April 2018

4 April 2018

Quick facts

Lead sponsor	Wake Forest University Health Sciences
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	21
Start date	26 June 2017
Primary completion	4 April 2018
Estimated completion	4 April 2018
Sites	1 location across United States

Drugs / interventions tested

HELP Prevent Cancer Intervention

Conditions studied

Obesity — all drugs for Obesity →
Cancer — all drugs for Cancer →

Sponsor

Wake Forest University Health Sciences

Who can join

21 and older, any sex, with Obesity or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study is designed to adapt a community-based diabetes prevention program to reach adults at risk for cancer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Patient navigator programmes for children and adolescents with chronic diseases.
Lalji R, Koh L, Francis A, Khalid R, et al · · 2024 · cited 7× · PMID 39382077 · DOI 10.1002/14651858.cd014688.pub2
Feasibility of an Adapted Community-Based Lifestyle Intervention to Prevent Cancer in the Rural South: Healthy Living Partnerships to Prevent Cancer (HELP PC).
Wise Thomas S, Blackwell Young C, Zoellner J, Brock DP, et al · · 2023 · PMID 35076863 · DOI 10.1007/s13187-022-02137-z

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02960542 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
Last refreshed: 19 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02960542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing